2023 - Research.com Microbiology in France Leader Award
Jean-Marc Rolain mainly focuses on Microbiology, Virology, Antibiotics, Antibiotic resistance and Polymerase chain reaction. His Microbiology research includes elements of Acinetobacter baumannii and Bacteria. He combines subjects such as Chloroquine, Coronavirus and Pneumonia with his study of Virology.
His research in Antibiotics intersects with topics in Pseudomonas aeruginosa and Teicoplanin. His work carried out in the field of Antibiotic resistance brings together such families of science as Biotechnology, Antimicrobial, Outbreak and Klebsiella pneumoniae. His studies in Polymerase chain reaction integrate themes in fields like rpoB and Staphylococcus aureus.
Microbiology, Virology, Antibiotics, Gene and Antibiotic resistance are his primary areas of study. His study of Colistin is a part of Microbiology. Jean-Marc Rolain has researched Colistin in several fields, including MCR-1, Enterobacteriaceae and Colistin resistance.
His research on Virology often connects related areas such as Polymerase chain reaction. In his study, Bacterial genetics is strongly linked to Drug resistance, which falls under the umbrella field of Antibiotic resistance. His Bartonella study combines topics in areas such as Bartonella henselae and Bartonella quintana.
Jean-Marc Rolain mainly investigates Microbiology, Antibiotic resistance, Antibiotics, Colistin and Gene. His Microbiology research integrates issues from MCR-1, Escherichia coli, Enterobacteriaceae, Colistin resistance and Klebsiella pneumoniae. His Antibiotic resistance study incorporates themes from One Health, Internal medicine and Multiple drug resistance.
The Antibiotics study combines topics in areas such as Veterinary medicine and Acinetobacter baumannii. In Colistin, Jean-Marc Rolain works on issues like Carbapenem, which are connected to Tigecycline. While the research belongs to areas of Chloroquine, Jean-Marc Rolain spends his time largely on the problem of Coronavirus Infections, intersecting his research to questions surrounding Coronavirus, Virology and Pneumonia.
The scientist’s investigation covers issues in Microbiology, Hydroxychloroquine, Coronavirus, Antibiotics and Internal medicine. The various areas that Jean-Marc Rolain examines in his Microbiology study include MCR-1, Colistin resistance and Escherichia coli. He has included themes like Virus, Chloroquine and Azithromycin in his Hydroxychloroquine study.
Jean-Marc Rolain combines subjects such as Pandemic, Pneumonia and Virology with his study of Coronavirus. His work in Virology tackles topics such as Betacoronavirus which are related to areas like Severe acute respiratory syndrome coronavirus 2. His work in Internal medicine covers topics such as Viral load which are related to areas like Regimen, Retrospective cohort study and Case fatality rate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
International Journal of Antimicrobial Agents (2020)
Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry
Piseth Seng;Michel Drancourt;Freédésrique Gouriet;Bernard La Scola.
Clinical Infectious Diseases (2009)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux;Christian A. Devaux;Jean Marc Rolain;Philippe Colson;Didier Raoult.
International Journal of Antimicrobial Agents (2020)
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Abiola Olumuyiwa Olaitan;Serge Morand;Jean-Marc Rolain.
Frontiers in Microbiology (2014)
Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19
Philippe Colson;Jean-Marc Rolain;Jean-Christophe Lagier;Philippe Brouqui.
International Journal of Antimicrobial Agents (2020)
ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes
Sushim Kumar Gupta;Babu Roshan Padmanabhan;Seydina M. Diene;Rafael Lopez-Rojas.
Antimicrobial Agents and Chemotherapy (2014)
The global threat of antimicrobial resistance: science for intervention
Ignasi Roca;Murat Akova;F. Baquero;Jean Carlet.
new microbes and new infections (2015)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
Travel Medicine and Infectious Disease (2020)
Culture of previously uncultured members of the human gut microbiota by culturomics
Jean-Christophe Lagier;Saber Khelaifia;Maryam Tidjani Alou;Sokhna Ndongo.
Nature microbiology (2016)
Recommendations for Treatment of Human Infections Caused by Bartonella Species
J. M. Rolain;P. Brouqui;J. E. Koehler;C. Maguina.
Antimicrobial Agents and Chemotherapy (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Grenoble Alpes University
Aix-Marseille University
Centre national de la recherche scientifique, CNRS
Aix-Marseille University
Centre national de la recherche scientifique, CNRS
National University of Singapore
Leiden University
Microsoft (United States)
National Cancer Centre
Michigan State University
University of Southern California
University of Los Lagos
Ruhr University Bochum
Lund University
Aarhus University
Jet Propulsion Lab
Desert Research Institute
University of Gothenburg
Norwegian University of Science and Technology
Harvard University
Austrian Academy of Sciences